Other

Reflecting on the basics of gratitude can help us find perspective and appreciate the good in our lives.

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the overachievers, and the ones still trying to find themselves (and that was before it was fashionable).

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your path was into biopharma (I was headed toward academic medicine with my MD/PhD but diverted for the reasons described below), or it could be the diverse companies where you’ve applied your skills (in my case, rare disease and oncology). It can even be the cities where you have lived (I transplanted to Boston from the Midwest over two decades ago; at some point, I expect to master driving here).

“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how the breakfast conversation began earlier this month between my Gen Z son and his boomer parents. To put this in context, you need to know that it was yet another rainy holiday weekend in New England, and we had already tested the limits of our togetherness. So this declarative headline was an appealing distraction.

When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for a district sales manager role. Boston, let alone the Marathon, just wasn’t part of my world.

You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However, this insight has stuck with me since Justice Sotomayor said it during her confirmation process in 2009.

It was March 2020 when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that COVID-19 had reached the threshold of a global pandemic.

In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies.